{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T14:09:29Z","timestamp":1792418969304,"version":"4.5.0"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T00:00:00Z","timestamp":1779840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T00:00:00Z","timestamp":1779840000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Blood Cancer J."],"DOI":"10.1038\/s41408-026-01532-9","type":"journal-article","created":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T21:03:16Z","timestamp":1779915796000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Gene- and subtype-dependent prognostic impact of ras pathway mutations in acute myeloid leukemia: a cohort study of 2,500 patients"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-1820-6164","authenticated-orcid":false,"given":"Heng","family":"Shen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Hui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuntao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shouyun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuyun","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5557-7291","authenticated-orcid":false,"given":"Benfa","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunlin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1532-0301","authenticated-orcid":false,"given":"Kaiqi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangji","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8938-3081","authenticated-orcid":false,"given":"Xiaoyuan","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3866-0066","authenticated-orcid":false,"given":"Shaowei","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingcheng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5060-5070","authenticated-orcid":false,"given":"Yingchang","family":"Mi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7485-0954","authenticated-orcid":false,"given":"Yan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9437-9151","authenticated-orcid":false,"given":"Jianxiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1674-3792","authenticated-orcid":false,"given":"Hui","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,27]]},"reference":[{"key":"1532_CR1","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.1056\/NEJMoa1301689","volume":"368","author":"The Cancer Genome Atlas Research Network.","year":"2013","unstructured":"The Cancer Genome Atlas Research Network. Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia. N Engl J Med. 2013;368:2059\u201374.","journal-title":"N Engl J Med"},{"key":"1532_CR2","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.1056\/NEJMoa1516192","volume":"374","author":"E Papaemmanuil","year":"2016","unstructured":"Papaemmanuil E, Gerstung M, Bullinger L, Gaidzik VI, Paschka P, Roberts ND, et al. Genomic classification and prognosis in acute myeloid leukemia. N Engl J Med. 2016;374:2209\u201321.","journal-title":"N Engl J Med"},{"key":"1532_CR3","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1182\/blood-2016-01-693879","volume":"128","author":"KH Metzeler","year":"2016","unstructured":"Metzeler KH, Herold T, Rothenberg-Thurley M, Amler S, Sauerland MC, G\u00f6rlich D, et al. Spectrum and prognostic relevance of driver gene mutations in acute myeloid leukemia. Blood. 2016;128:686\u201398.","journal-title":"Blood"},{"key":"1532_CR4","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1016\/j.bbamcr.2007.05.001","volume":"1773","author":"DT Leicht","year":"2007","unstructured":"Leicht DT, Balan V, Kaplun A, Singh-Gupta V, Kaplun L, Dobson M, et al. Raf kinases: Function, regulation and role in human cancer. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 2007;1773:1196\u2013212.","journal-title":"Biochimica et Biophysica Acta (BBA) - Molecular Cell Research"},{"key":"1532_CR5","doi-asserted-by":"publisher","first-page":"4603","DOI":"10.1200\/JCO.2007.14.0418","volume":"26","author":"A Neubauer","year":"2008","unstructured":"Neubauer A, Maharry K, Mr\u00f3zek K, Thiede C, Marcucci G, Paschka P, et al. Patients with acute myeloid leukemia and ras mutations benefit most from postremission high-dose cytarabine: a cancer and leukemia Group B study. JCO. 2008;26:4603\u20139.","journal-title":"JCO"},{"key":"1532_CR6","doi-asserted-by":"publisher","first-page":"5550","DOI":"10.1002\/cncr.27596","volume":"118","author":"TM Kadia","year":"2012","unstructured":"Kadia TM, Kantarjian H, Kornblau S, Borthakur G, Faderl S, Freireich EJ, et al. Clinical and proteomic characterization of acute myeloid leukemia with mutated RAS. Cancer. 2012;118:5550\u20139.","journal-title":"Cancer"},{"key":"1532_CR7","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.6004\/jnccn.2013.0127","volume":"11","author":"MR O\u2019Donnell","year":"2013","unstructured":"O\u2019Donnell MR, Tallman MS, Abboud CN, Altman JK, Appelbaum FR, Arber DA, et al. Acute Myeloid Leukemia, Version 2.2013. J Natl Compr Canc Netw. 2013;11:1047\u201355.","journal-title":"J Natl Compr Canc Netw"},{"key":"1532_CR8","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1073\/pnas.87.4.1377","volume":"87","author":"SA Ridge","year":"1990","unstructured":"Ridge SA, Worwood M, Oscier D, Jacobs A, Padua RA. FMS mutations in myelodysplastic, leukemic, and normal subjects. Proc Natl Acad Sci USA. 1990;87:1377\u201380.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1532_CR9","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1038\/s41392-023-01705-z","volume":"8","author":"ME Bahar","year":"2023","unstructured":"Bahar ME, Kim HJ, Kim DR. Targeting the RAS\/RAF\/MAPK pathway for cancer therapy: from mechanism to clinical studies. Sig Transduct Target Ther. 2023;8:455.","journal-title":"Sig Transduct Target Ther"},{"key":"1532_CR10","doi-asserted-by":"publisher","first-page":"2536","DOI":"10.1038\/s41375-018-0147-4","volume":"32","author":"AK Eisfeld","year":"2018","unstructured":"Eisfeld AK, Kohlschmidt J, Mr\u00f3zek K, Mims A, Walker CJ, Blachly JS, et al. NF1 mutations are recurrent in adult acute myeloid leukemia and confer poor outcome. Leukemia. 2018;32:2536\u201345.","journal-title":"Leukemia"},{"key":"1532_CR11","doi-asserted-by":"publisher","first-page":"583","DOI":"10.3324\/haematol.2020.269431","volume":"107","author":"T Kaburagi","year":"2021","unstructured":"Kaburagi T, Yamato G, Shiba N, Yoshida K, Hara Y, Tabuchi K, et al. Clinical significance of RAS pathway alterations in pediatric acute myeloid leukemia. haematol. 2021;107:583\u201392.","journal-title":"haematol"},{"key":"1532_CR12","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1080\/10428194.2024.2441855","volume":"66","author":"F Zhang","year":"2025","unstructured":"Zhang F, Liu Y, Zhu Y, Wang Q, Zhao X, Wang Q, et al. Molecular, clinical, and prognostic implications of RAS pathway alterations in adult acute myeloid leukemia. Leukemia & Lymphoma. 2025;66:753\u201363.","journal-title":"Leukemia & Lymphoma"}],"container-title":["Blood Cancer Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41408-026-01532-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41408-026-01532-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41408-026-01532-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T21:03:16Z","timestamp":1779915796000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41408-026-01532-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,27]]},"references-count":12,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1532"],"URL":"https:\/\/doi.org\/10.1038\/s41408-026-01532-9","relation":{},"ISSN":["2044-5385"],"issn-type":[{"value":"2044-5385","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,27]]},"assertion":[{"value":"2 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All methods were performed in accordance with the relevant guidelines and regulations. The study was approved by the Blood Diseases Hospital Ethics Committee and conducted in accordance with the Declaration of Helsinki. Written informed consent for treatment was obtained from all patients.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}],"article-number":"82"}}